Risk assessment of medicinal products on human reproduction and lactation: from data to labelling

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMEA/CHMP/203927/05
Effective from01/01/2009
KeywordsPregnancy, lactation, contraindication, non-clinical assessment, clinical assessment, risk assessment, labelling, summary of product characteristics (SmPC)
DescriptionThis document describes how to assess the risk of an adverse reproductive/developmental effect in human based on reproductive toxicity studies in animals and human clinical data. It addresses information to be included in the summary of product characteristics on how to use the medicinal product taking into account the nature of the risk.

Document history

First version

Current version

Adopted guideline

Draft guideline

In operation: 01/01/2009–present

Published: 23/03/2006

Related content

How helpful is this page?

Average rating:

 Based on 22 ratings

Add your rating:

See all ratings
4 ratings
4 ratings
4 ratings
4 ratings
6 ratings

Tell us more